However, an increased tumor burden in Akt2 null mice is not consistently seen in mouse models of lung cancer [41] or other tumors such as mammary tumors [89], which would be expected if hyperglycemia was the driving force behind accelerated tumorigenesis in Akt2−/− models. This evidence concerns the gene AKT2 and breast cancer.